VEGFA Recombinant Antibody, FITC Conjugated
Product Specifications
Background
Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth.
Synonyms
Vascuoar endothelial growth factor A; VEGF A; vascular endothelial growth factor A isoform 2 precursor; MGC70609; MVCD1; VEGF; VPF; VEGFA_HUMAN; VEGF-A; Vascular permeability factor (VPF)
Cellular Locus
Secreted
Host
Rabbit
Cross Reactivity
Human
Target
VEGFA
Clonality
Recombinant
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human VEGF
Applications
IF
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
Lot dependent
Dilution
IF ()
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Human Multiple Myeloma Cells [MM.1R]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
MBS6276544-01 0.1 mL
ATP5G1, ID (ATP5G1, ATP synthase lipid-binding protein, mitochondrial, ATP synthase proteolipid P1, ATPase protein 9, ATPase subunit c) (MaxLight 750)
Ask
View Details